bpc-157 human clinical trials safety fda warning Exciting news for peptides coming out of today's committee hearing! The Pharmacy Compounding Advisory Committee voted 8-6 to recommend adding BPC- 157 to the 503A Bulks List for use in compounding for FDA panel backs easier access

Braun-Falcos Dermatology

When it comes to the gut, apigenin affects Enterococcus caccae cell wall/membrane synthesis and increases the incidence of protein misfolding Bacteroides galacturonicus growth was also inhibited by apigenin[and] apigenin promoted overall growth and diversity, lowered Firmicutes to Bacteroidetes ratio, and promoted production of short chain fatty acids, including butyrate, which is associated with health (Wang et al., 2017)

Consider Leave-On Contact Time Leave-on serums usually remain in contact with the scalp longer than shampoos or conditioners

Safety-First Monitoring & Medical Oversight We monitor hormonal markers, metabolic response, and overall health progress to ensure safe dosing and timely treatment adjustments

We proudly use pharmaceutical-grade compounded peptides sourced from trusted, licensed U.S